Connect with us

Politics

Former VA Secretary Who Oversaw Marijuana Research Blockade Now Backs Cannabis Studies For Veterans

Published

on

Former U.S. Department of Veterans Affairs (VA) Secretary David Shulkin is officially on board with having the department research medical marijuana—a development that comes a year after he was in a position to actually make that happen.

In an interview with Task & Purpose that was published on Thursday, Shulkin said that “the time is now” for VA to facilitate studies into the therapeutic potential of cannabis for veterans.

“I believe that the VA should be involved in research on anything that could potentially help veterans and improve their health and well-being,” he said.

That appears to represent a notable departure from the position he held while he headed the department.

For example, VA under his leadership refused to provide assistance to an Arizona-based research facility that was soliciting veterans to participate in a federally approved clinical trial looking at the potential benefits of cannabis in the treatment of post-traumatic stress disorder (PTSD).

“Federal law restricts VA’s ability to conduct research involving medical marijuana, or to refer veterans to such research projects,” a VA official told Air Force Times in 2017. “The researcher is free to work with veterans service organizations and state veterans officials who may not face such restrictions to identify candidates for her study.”

But according to the Brookings Institute, that’s not an accurate assessment because “doctors and researchers at the VA or in VA hospitals could conduct research into the medical efficacy of marijuana while remaining completely compliant with federal laws, regulations, and the United States’ obligations under international agreements.”

While the former secretary still said during this latest interview that congressional action is necessary to prompt VA research efforts, he seems to have become decidedly more vocal about the importance of such studies as compared to his time in office.

“In particular, with the VA’s focus on suicide as the top priority, people just don’t take their lives because of no reason,” he said. “They take their lives, often because of issues related to chronic pain, depression, substance abuse, and there is growing evidence that medical marijuana—I’m not talking about recreational marijuana—but properly prescribed, may have some real benefits in anxiety improvement, in pain management, and potentially, in the issue of substance abuse.”

“And therefore, I believe it’s extremely appropriate for VA to be researching and developing therapies that can help veterans, particularly in areas where we don’t have enough good therapies or answers,” he said.

Task & Purpose followed up to ask about potential obstacles such to having VA conduct research into the issue, and Shulkin said that because marijuana is a federally controlled substance, “the challenge of doing research with the regulations, and the hoops that you have to go through, are making it too difficult to do for many of the researchers.”

“I do think that the way forward is a legislative solution, much of what VA responds to are changes in the law, where medical research for veterans in this area could be streamlined and clarity around what regulations and rules need to be followed to be able to do this research, as well as guidance about the type of research that can and should be done, which reports back to Congress.”

He added that he doesn’t anticipate that President Trump would resist legislation empowering VA to study marijuana for veterans.

Brad Burge, director of strategic communication at the Multidisciplinary Association for Psychedelic Studies (MAPS), the group behind the study into cannabis for PTSD, told Marijuana Moment that they are “pleased that Shulkin has now expressed his support for medical marijuana research, even though that support would have been much more valuable when he was still in office.”

“Nevertheless we are looking forward to the VA’s support of marijuana research and see Shulkin’s change of stance as a promising sign for veterans suffering from PTSD,” Burge said.

It wasn’t just that Shulkin’s VA put up roadblocks to cannabis research, he also resisted providing veterans with access to marijuana by declining to change internal VA policy that could empower its doctors to issue recommendations in states where it’s legal.

The reasoning, he said in 2017, is that it’s “not within our legal scope to study that in formal research programs or to prescribe medical marijuana, even in states where it’s legal” because of federal law. But advocates argued that the only thing standing in the way of VA cannabis research is VA policy itself, which Shulkin could have amended.

Getting a VA cannabis reform bill passed as the former official is now recommending has already proved difficult this year, with current VA officials voicing opposition during a congressional committee hearing in June to modest proposals such as allowing their doctors to recommend cannabis or even surveying veterans about their marijuana use.

Rep. Earl Blumenauer (D-OR) said that same month that he pulled an appropriations amendment to allow for VA marijuana recommendations from floor consideration partly because of opposition from the department.

Former FDA Chief Wants Federal Government To Regulate State Marijuana Markets

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

AOC Blasts Biden’s ‘Reagan-Era’ Marijuana Talking Points

Published

on

Former Vice President Joe Biden’s suggestion that cannabis could be a gateway drug was “risky” and a “Reagan-era talking point,” Rep. Alexandria Ocasio-Cortez (D-NY) said in an interview with Marijuana Moment on Tuesday.

While the congresswoman said she acknowledged that “there are folks, when it comes to the marijuana issue, that have a wide range of opinions within the Democratic party,” she also feels that “we have moved on as a country” on the need to end cannabis prohibition.

“These are Reagan-era talking points that were behind one of the worst and most shameful phases of American policy, which is mass incarceration,” Ocasio-Cortez said, referencing the former Republican president’s anti-drug crusade that largely relied on fear-mongering and campaigns such as “Just Say No.”

“That rhetoric is rhetoric of mass incarceration. The only thing that marijuana, due to the failures of U.S. policy, is a gateway to is our mass incarceration system.”

“That needs to end, marijuana needs to be legalized, drugs need to be decriminalized for consumption,” she said. “These are very simple issues of public health.”

The congresswoman first voiced support for decriminalizing all drugs in a tweet on Sunday; she previously called for decriminalizing the consumption of psychedelics alone in a video taped for activists at a drug policy reform conference earlier this month.

Biden, who played a central role in enacting punitive drug laws during his time in the Senate, has been sharply rebuked by reform advocates after he said on Saturday that “there’s not nearly been enough evidence that has been acquired as to whether or not [cannabis] is a gateway drug” and that he wanted to see more debate on the issue “before I legalize it nationally.”

Sens. Bernie Sanders (I-VT) and Kamala Harris (D-CA), both presidential candidates, also seemed to criticize Biden, implicitly contrasting his comments with their respective plans to end federal marijuana prohibition. Entrepreneur Andrew Yang told CNN that he thinks “Joe actually will end up evolving on this issue over time if he sees the same evidence that I have.”

Ocasio-Cortez, in the new interview with Marijuana Moment, said she feels as if “any person who has had, like me, family, friends, neighbors that have been stopped, frisked, incarcerated and trapped in this system would know how risky of a statement that is,” referring to Biden’s “gateway drug” comments.

She also weighed in on the debate over what kind of marijuana reform legislation should be pursued in Congress, as the House Judiciary Committee prepares to mark up legislation from Chairman Jerrold Nadler (D-NY) that would federally deschedule cannabis and address social equity issues.

While some have voiced concerns that pursuing a wide-ranging legalization bill—as opposed to something more narrowly tailored and states’ rights-focused—will slow down the reform process given the current makeup of the Senate, the congresswoman said that with “matters of justice, it’s not about slowing it down, it’s about doing it right.”

“The problem is that if we don’t pass a bill with the social elements inside it then we compound on the racial wealth gap, we compound on the same folks who got rich off of private prisons are going to turn around, invest those profits into legal marijuana and we’re going to have the same economic discrimination that we had,” she said.

“If we just pass the financial piece, it’s just going to be another Wall Street market that’s going to exploit people so we can’t go down that road,” she added, referencing a House-passed bill that would protect banks that service marijuana businesses from being penalized by federal regulators.

Aaron Houston contributed reporting for this story from Washington, D.C.

Marijuana Legalization Will Get A Floor Vote This Congress, Key Chairman Predicts

Photo elements courtesy of Russia and nrkbeta.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Virginia Marijuana Decriminalization Bill Filed For 2020 After Democrats Reclaim Legislature

Published

on

A Virginia lawmaker prefiled a bill on Monday for the 2020 session that would decriminalize the possession of marijuana—a piece of reform legislation that stands a much better chance of passing after voters elected Democratic majorities in both chambers of the legislature earlier this month.

Sen. Adam Ebbin (D) introduced the proposal, which would make possession of up to one ounce of cannabis punishable by a maximum $50 civil penalty. Currently, simple possession carries up to a $500 fine and 30 days in jail.

Decriminalization was among the campaign promises made by Gov. Ralph Northam (D), who also called for the policy change in his State of the State address in January, but reform efforts have stalled to date in the Republican-controlled legislature.

The governor said earlier this month that decriminalization is a 2020priority for his administration, a goal that now appears much more achievable since Democrats have reclaimed control of both the House of Delegates and Senate.

“The new majority creates a real pathway for the passage of decriminalization in the 2020 General Assembly,” Jenn Michelle Pedini, executive director of Virginia NORML, told Marijuana Moment. “SB2 is a common sense approach to a policy supported by three out of four Virginians.”

Here’s how the bill would amend the state’s law on cannabis possession:  

“Any person who violates this section is guilty of a misdemeanor and shall be confined in jail not more than 30 days and fined not subject to a civil penalty of no more than $500, either or both; any person, upon a second or subsequent conviction of a violation of this section, is guilty of a Class 1 misdemeanor $50. Any civil penalties collected pursuant to this section shall be deposited into the Drug Offender Assessment and Treatment Fund.”

Additionally, the legislation would make it so that only individuals who’ve committed criminal violations, or juveniles who’ve committed civil violations, would be subject to penalties such as a suspended sentence, substance abuse screening or driver’s license suspension.

“The bill also allows a person to petition for expungement of convictions and deferred disposition dismissals for marijuana possession when all court costs and fines and orders of restitution have been paid,” a summary states.

While it’s yet to be seen whether the new legislature will pursue broader reform such as adult-use legalization or an expansion of the state’s limited medical cannabis program, recent polling indicates that Virginians are ready to move ahead. Sixty-one percent of Virginia residents favor recreational legalization, according to a survey released in September.

New Jersey Voters Will Decide On Marijuana Legalization Next Year, Senate Leaders Say

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Marijuana Legalization Will Get A Floor Vote This Congress, Key Chairman Predicts

Published

on

The chairman of the House Judiciary Committee said on Tuesday that he’s optimistic about the prospects for getting his comprehensive marijuana legalization bill out of committee and onto the floor by the end of this Congress.

During a press conference with lawmakers and advocates, Chairman Jerrold Nadler (D-NY) also told Marijuana Moment that part of the reason he expects floor time is because he’s actively communicating with other committee chairs, requesting that they waive jurisdiction of the reform legislation to expedite its progress.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act, introduced by Nadler, would federally deschedule cannabis and provide for expungements and reinvestments in communities most impacted by the war on drugs. The panel confirmed that members will mark up the legislation on Wednesday at 10:00 AM ET.

The chairman—as well as Reps. Barbara Lee (D-CA), Earl Blumenauer (D-OR), Nydia Velázquez (D-NY), Steve Cohen (D-TN), Pramila Jayapal (D-WA) and the executive directors of the Drug Policy Alliance (DPA) and Law Enforcement Action Partnership (LEAP)—spoke at the event.

Watch lawmakers discuss the federal marijuana legalization vote below: 

While the MORE Act has been referred to seven additional committees, Nadler told Marijuana Moment that his panel is “carrying on conversations” about getting other panels to waive jurisdiction.

“I don’t anticipate that to be a big problem,” he said. “We are looking forward to moving this to the floor at an appropriate time when we’ve done some more educational work and have the votes.”

“For too long, our federal cannabis policies have been rooted in the past,” Lee, who serves as co-chair of the Congressional Cannabis Caucus, said, adding that this bill is “rooted in equality, justice and fairness.”

Blumenauer said that the country has “seen more progress is the last 40 months than we’ve seen in the last 40 years” when it comes to marijuana policy.

“We shouldn’t settle any longer for incremental change,” he said. “We must commit to the restorative justice that’s in this.”

“This is the Congress that can end the failed prohibition of cannabis.”

Nadler said that he expects the bill to clear his panel with bipartisan support, predicting that more Republican members will sign onto the legislation as it advances.

To that end, Rep. Matt Gaetz (R-FL), who is so far the lone GOP cosponsor of the MORE Act, told Marijuana Moment that he’s “pleased to see historic steps being taken in the Judiciary Committee on the issue of cannabis.”

“The MORE Act is not perfect, but it advances the discussion on cannabis reform and allows the Congress to take much-needed action on this important issue,” the congressman, who is a member of the Judiciary Committee, said. “I look forward to participating in the discussion this week.”

Nadler left open the possibility that lawmakers could make compromises on the legislation later down the road, but he added that he doesn’t believe it will have to come to that, and that it would be a mistake to scale down the legislation at this early stage of the process.

“This will remove a stain on people’s record but really a stain on the United States of America,” Cohen said. He also joked that when Blumenauer described the bill as the “best piece of cannabis legislation” he’s seen, another way of putting it is that the MORE Act is the “Acapulco Gold of marijuana legislation,” referencing a variety of cannabis popular in the 1960s.

Maria McFarland Sánchez-Moreno, executive director of DPA, said that “marijuana prohibition has, for millions of black and brown people in the U.S., been the gateway to arrests, incarceration, loss of livelihoods and lives.”

“Those are concrete, real harms, that affect real people every day,” she said. “Continuing the status quo of prohibition is not just inaction: it means turning your back on those harms, and condemning hundreds of thousands every year to continuing that misery and oppression.”

“What is most important here [is] this will free up law enforcement resources to a great level,” Neill Franklin of LEAP said. “I hope that others realize what this will do for public safety coast-to-coast in this country.”

Rep. Lou Correa (D-CA) tweeted support for the MORE Act during the press conference and said that “[a]s more states fully legalize cannabis, it’s time for Congress to decriminalize it.”

There’s been significant pressure from reform advocates to advance the legislation, especially since the full House overwhelmingly approved a bill that would protect banks servicing marijuana businesses from being penalized by federal regulators.

Several reform groups, including the ACLU, wrote a letter to House leadership ahead of that vote asking for a delay, arguing that Congress must pass comprehensive legalization that addresses social equity concerns before moving ahead with legislation viewed as largely favorable to the industry.

Meanwhile, some feel that the House would be better off voting on a more limited, states’ rights-focused reform bill such as the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, which would simply carve out an exception in federal law allowing states to implement cannabis programs, because they believe it stands a better chance at passing in the GOP-controlled Senate.

While observers generally expect the MORE Act to pass out of committee as well as the House, there are still questions about what kind of amendments members might offer and how that will impact the vote.

In any case, Wednesday’s vote will be one of the most highly anticipated congressional developments in the cannabis reform movement, with members not just debating the end of federal prohibition—which happened in a House subcommittee in July—but actually voting on a bill that would accomplish that, and more.

Aaron Houston contributed reporting for this story from Washington, D.C. This post was updated to include remarks from the press conference.

Key Congressional Committee Officially Schedules Vote On Marijuana Legalization Bill

Image element courtesy of Tim Evanson

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!